| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2238384 | 1984-08-22 | ||
| IT22383/84AIT1175620B (it) | 1984-08-22 | 1984-08-22 | Derivati piridinici |
| IT21460/85AIT1187678B (it) | 1985-07-05 | 1985-07-05 | Procedimento di preparazione di derivati eterociclici |
| IT2146085 | 1985-07-05 |
| Publication Number | Publication Date |
|---|---|
| DK378085D0 DK378085D0 (da) | 1985-08-20 |
| DK378085Atrue DK378085A (da) | 1986-02-23 |
| DK165949B DK165949B (da) | 1993-02-15 |
| DK165949C DK165949C (da) | 1993-07-05 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK378085ADK165949C (da) | 1984-08-22 | 1985-08-20 | 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne |
| Country | Link |
|---|---|
| US (2) | US4801599A (da) |
| JP (2) | JPS6193162A (da) |
| KR (1) | KR920004482B1 (da) |
| AT (1) | AT394042B (da) |
| AU (1) | AU578724B2 (da) |
| BE (1) | BE903103A (da) |
| BG (1) | BG60409B2 (da) |
| CA (1) | CA1268180A (da) |
| CH (1) | CH666684A5 (da) |
| CS (1) | CS403091A3 (da) |
| CY (1) | CY1494A (da) |
| DE (1) | DE3529997C2 (da) |
| DK (1) | DK165949C (da) |
| ES (5) | ES8703839A1 (da) |
| FI (1) | FI81568C (da) |
| FR (1) | FR2569402B1 (da) |
| GB (1) | GB2164336B (da) |
| GR (1) | GR852016B (da) |
| HK (1) | HK52990A (da) |
| HU (1) | HU196754B (da) |
| IE (1) | IE58486B1 (da) |
| LU (2) | LU86047A1 (da) |
| MX (1) | MX159974A (da) |
| NL (2) | NL193065C (da) |
| NO (2) | NO167142C (da) |
| NZ (1) | NZ212895A (da) |
| PH (1) | PH22014A (da) |
| PT (1) | PT81000B (da) |
| SA (1) | SA91120277B1 (da) |
| SE (1) | SE459920B (da) |
| SG (1) | SG40889G (da) |
| SK (1) | SK278327B6 (da) |
| ZW (1) | ZW13185A1 (da) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ212895A (en)* | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
| DE3675747D1 (de)* | 1985-08-21 | 1991-01-03 | Glaxo Spa | 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung. |
| SE465367B (sv)* | 1985-08-21 | 1991-09-02 | Glaxo Spa | Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar |
| IT1204462B (it)* | 1986-02-20 | 1989-03-01 | Glaxo Spa | Derivati eterociclici |
| IT1204461B (it)* | 1986-02-20 | 1989-03-01 | Glaxo Spa | Derivati eterociclici |
| IT1204460B (it)* | 1986-02-20 | 1989-03-01 | Glaxo Spa | Derivati eterociclici |
| IT1233370B (it)* | 1988-11-21 | 1992-03-27 | Glaxo Spa | Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari |
| US5102709A (en) | 1989-04-27 | 1992-04-07 | Canon Kabushiki Kaisha | Optical recording medium and process for production thereof |
| US5196529A (en)* | 1990-10-09 | 1993-03-23 | Merck & Co., Inc. | 2-phenanthrenyl carbapenem intermediates |
| US5177202A (en)* | 1990-10-09 | 1993-01-05 | Merck & Co., Inc. | 2-phenanthrenyl-carbapenems |
| US5132422A (en)* | 1990-10-09 | 1992-07-21 | Merck & Co., Inc. | 2-naphthyl-carbapenem intermediates |
| US5132421A (en)* | 1990-10-09 | 1992-07-21 | Merck & Co., Inc. | 2-naphthyl-carbapenem intermediates |
| US5356889A (en)* | 1990-08-01 | 1994-10-18 | Merck & Co., Inc. | 2-(9-fluorenonyl)-carbapenem intermediates |
| US5144028A (en)* | 1990-10-09 | 1992-09-01 | Merck & Co., Inc. | 2-(9-fluorenonyl)-carbapenem intermediates |
| US5208329A (en)* | 1990-10-09 | 1993-05-04 | Merck & Co., Inc. | 2-biphenyl carbapenem intermediates |
| IT1244728B (it)* | 1991-02-13 | 1994-08-08 | Glaxo Spa | Impiego medicamentoso di derivati diidropiridinici |
| TW483763B (en)* | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
| AU1042199A (en)* | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Antihypertensive medicaments containing lacidipine and telmisartan |
| EP1545519B1 (en) | 2002-08-19 | 2011-03-23 | Pfizer Inc. | Combination therapy for hyperproliferative diseases |
| AU2004242777B2 (en)* | 2003-05-30 | 2011-05-12 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as HMG-Co inhibitors |
| US20050037063A1 (en)* | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
| AU2005269465A1 (en)* | 2004-07-26 | 2006-02-09 | Cotherix, Inc. | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| EP1868577A4 (en) | 2005-04-15 | 2009-12-09 | Reddys Lab Inc Dr | Lacidipine PARTICLE |
| US20070043088A1 (en)* | 2005-08-16 | 2007-02-22 | Eswaraiah Sajja | Process for preparing lacidipine |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| EP1951253A2 (en) | 2005-10-26 | 2008-08-06 | Cotherix, Inc. | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| CA2627599A1 (en)* | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| TW200744583A (en)* | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
| WO2008010087A2 (en)* | 2006-07-14 | 2008-01-24 | Ranbaxy Laboratories Limited | Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof |
| US20080089947A1 (en)* | 2006-08-18 | 2008-04-17 | Knox Clayton D | Calcium Influx Inhibitors in the Treatment of Ischemia |
| EP2094643B1 (en) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| US8883844B2 (en) | 2010-09-24 | 2014-11-11 | Nitrogenix Inc. | Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions |
| LT2705839T (lt) | 2012-09-10 | 2018-06-11 | Rivopharm Sa | Farmacinė kompozicija, apimanti lacidipiną ir jos gavimo būdas |
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| ES3007652T3 (en) | 2019-01-18 | 2025-03-20 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455945A (en)* | 1967-06-07 | 1969-07-15 | Smithkline Corp | 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines |
| DE2228363A1 (de)* | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB1409865A (en)* | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
| US4307103A (en)* | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
| DE3018259A1 (de)* | 1980-05-13 | 1981-11-19 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| NZ201395A (en)* | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3207982A1 (de)* | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| NZ212895A (en)* | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
| Publication | Publication Date | Title |
|---|---|---|
| DK378085D0 (da) | Heterocycliske derivater | |
| DK268285A (da) | Dialkoxypyridinderivater | |
| DK35785A (da) | Tetrahydrocarbazolonderivater | |
| DK243985A (da) | Aminoalkylphenoxyderivater | |
| DE3463503D1 (de) | Sulfonamido-benzamide derivatives | |
| DK106786A (da) | Heterocycliske forbindelser | |
| DE3572358D1 (de) | Thienyl condensed-pyrazole derivatives | |
| DK552685D0 (da) | Heterocycliske forbindelser | |
| DK162485D0 (da) | Heterocykliske forbindelser | |
| DE3566887D1 (de) | Flavanon derivatives | |
| DK524585D0 (da) | Cholecalciferolderivater | |
| DK219986A (da) | Nitrogenholdige heterocycliske forbindelser | |
| DK501085A (da) | Substituerede benzimidazolderivater | |
| DK460785A (da) | Substituerede furanylderivater | |
| DK443685A (da) | Pirimidinderivater | |
| DK121282A (da) | Heterocykliske derivater | |
| DK320585A (da) | Fluorallylaminderivater | |
| ES539508A0 (es) | Derivados de androsteno nuevos | |
| DK333785D0 (da) | Mevalonolactonderivater | |
| DK514585D0 (da) | Aminoethylanilinderivater | |
| DK496885A (da) | Heterocycliske forbindelser | |
| DE3565100D1 (de) | Cycloalkane-indene-carboximidamide derivatives | |
| DK267190A (da) | 13-substitueret-5-ketomilbemycinderivater | |
| DK54085D0 (da) | Phenylpropargylaminderivater | |
| DK109586A (da) | Heterocycliske forbindelser |
| Date | Code | Title | Description |
|---|---|---|---|
| CTFF | Application for supplementary protection certificate (spc) filed | Free format text:CA 1997 00018, 970410 | |
| CTFG | Supplementary protection certificate (spc) issued | Free format text:CA 1997 00018, 970410, EXPIRES: 20051107 | |
| PUP | Patent expired |